REMICADE - infliximab
Navigation: NDC > Supplier starting with: J > JANSSEN BIOTECH, INC.| Field | Value |
|---|---|
| NDC Code: | 57894-030 |
| Proprietary Name: | REMICADE |
| Suffix: | |
| Non-Proprietary Name: | infliximab |
| Dosage Form: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 24-08-1998 |
| Category Name: | BLA |
| Application Number: | BLA103772 |
| Labeler: | JANSSEN BIOTECH, INC. |
| Substance Name: | INFLIXIMAB |
| Active Numerator Strength: | 100 |
| Active Ingredient Unit: | mg/10mL |
| Pharm Classes: | Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
| DEA Schedule: |